195 related articles for article (PubMed ID: 27389717)
21. Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin.
Schaefer AV; Leslie BA; Rischke JA; Stafford AR; Fredenburgh JC; Weitz JI
Biochemistry; 2006 Apr; 45(13):4257-65. PubMed ID: 16566600
[TBL] [Abstract][Full Text] [Related]
22. Structural difference between polymerized and non-polymerized fragment X, obtained by plasmin digest of fibrinogen.
Sato H; Swadesh JK
Int J Biol Macromol; 1993 Dec; 15(6):323-7. PubMed ID: 8110652
[TBL] [Abstract][Full Text] [Related]
23. Interaction of one-chain and two-chain tissue plasminogen activator with intact and plasmin-degraded fibrin.
Higgins DL; Vehar GA
Biochemistry; 1987 Dec; 26(24):7786-91. PubMed ID: 2962641
[TBL] [Abstract][Full Text] [Related]
24. Protective effect of divalent cations in the plasmin degradation of fibrinogen.
Dang CV; Bell WR; Ebert RF; Starksen NF
Arch Biochem Biophys; 1985 May; 238(2):452-7. PubMed ID: 3158281
[TBL] [Abstract][Full Text] [Related]
25. [Kinetics of fibrin lysis by plasmin: inhibition by fibrin degradation products].
Zhitkova IuV; Aĭsina RB; Varfolomeev SD
Bioorg Khim; 1996 Dec; 22(12):911-5. PubMed ID: 9054342
[TBL] [Abstract][Full Text] [Related]
26. Decreased plasmin resistance by clots of a homophenotypic Aalpha R 16H fibrinogen (Kingsport, slower fibrinopeptide A than fibrinopeptide B release).
Galanakis DK; Neerman-Arbez M; Kudryk B; Henschen A
Blood Coagul Fibrinolysis; 2010 Mar; 21(2):135-9. PubMed ID: 20019599
[TBL] [Abstract][Full Text] [Related]
27. Crystallization of fragment D from human fibrinogen.
Everse SJ; Pelletier H; Doolittle RF
Protein Sci; 1995 May; 4(5):1013-6. PubMed ID: 7663337
[TBL] [Abstract][Full Text] [Related]
28. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
Doolittle RF; Pandi L
Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
[TBL] [Abstract][Full Text] [Related]
29. Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin.
Goodwin CA; Kakkar VV; Scully MF
Biochem J; 1992 Feb; 281 ( Pt 3)(Pt 3):613-8. PubMed ID: 1531588
[TBL] [Abstract][Full Text] [Related]
30. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
Bi Oh S; Suh N; Kim I; Lee JY
Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
[TBL] [Abstract][Full Text] [Related]
31. The degradation of Abeta(25-35) by the serine protease plasmin is inhibited by aluminium.
Korchazhkina OV; Ashcroft AE; Kiss T; Exley C
J Alzheimers Dis; 2002 Oct; 4(5):357-67. PubMed ID: 12446968
[TBL] [Abstract][Full Text] [Related]
32. β-Amyloid Orchestrates Factor XII and Platelet Activation Leading to Endothelial Dysfunction and Abnormal Fibrinolysis in Alzheimer Disease.
García-Mejía KA; Custodio-Chablé SJ; Vázquez-Franco JE; Reyes-Maldonado E; Lezama RA
Alzheimer Dis Assoc Disord; 2021 Jan-Mar 01; 35(1):91-97. PubMed ID: 33629978
[TBL] [Abstract][Full Text] [Related]
33. Plasmin generation and fibrin(ogen)olysis following desmopressin infusion.
Takahashi H; Tatewaki W; Wada K; Niwano H; Hanano M; Shibata A
Am J Hematol; 1991 Apr; 36(4):255-8. PubMed ID: 1826408
[TBL] [Abstract][Full Text] [Related]
34. Fibrinogen degradation product fragment D induces endothelial cell detachment by activation of cell-mediated fibrinolysis.
Ge M; Tang G; Ryan TJ; Malik AB
J Clin Invest; 1992 Dec; 90(6):2508-16. PubMed ID: 1281836
[TBL] [Abstract][Full Text] [Related]
35. Interaction of fibrin(ogen) with fibronectin: further characterization and localization of the fibronectin-binding site.
Makogonenko E; Tsurupa G; Ingham K; Medved L
Biochemistry; 2002 Jun; 41(25):7907-13. PubMed ID: 12069579
[TBL] [Abstract][Full Text] [Related]
36. Fibrinogenolytic and fibrinolytic activity of cell-associated plasmin.
Humphries JE; Vasudevan J; Gonias SL
Arterioscler Thromb; 1993 Jan; 13(1):48-55. PubMed ID: 7678497
[TBL] [Abstract][Full Text] [Related]
37. [Fibrinogen fragment D - inhibitor of fibrinolytic processes].
Rozenfel'd MA; Fateeva LA; Gontar' ID
Biokhimiia; 1983 Jul; 48(7):1135-40. PubMed ID: 6225469
[TBL] [Abstract][Full Text] [Related]
38. Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen (plasmin fragments Y).
Nieuwenhuizen W; Voskuilen M; Hermans J
Biochim Biophys Acta; 1982 Nov; 708(3):313-6. PubMed ID: 6216917
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of novel tPA- and plasminogen-binding sites within fibrin(ogen) alpha C-domains.
Tsurupa G; Medved L
Biochemistry; 2001 Jan; 40(3):801-8. PubMed ID: 11170397
[TBL] [Abstract][Full Text] [Related]
40. Alzheimer's Amyloid-β Sequesters Caspase-3 in Vitro via Its C-Terminal Tail.
Chang YJ; Linh NH; Shih YH; Yu HM; Li MS; Chen YR
ACS Chem Neurosci; 2016 Aug; 7(8):1097-106. PubMed ID: 27227450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
